位置:成果数据库 > 期刊 > 期刊详情页
菩人丹对2型糖尿病胰腺微循环损伤大鼠VEGF及其受体VEGFR2/p-VEGFR2和Angiostatin、Endostatin的影响
  • ISSN号:1673-6613
  • 期刊名称:《世界中西医结合杂志》
  • 时间:0
  • 分类:R587[医药卫生—内分泌;医药卫生—临床医学;医药卫生—内科学]
  • 作者机构:[1]中央民族大学中国少数民族传统医学研究院,北京100081
  • 相关基金:国家自然科学基金(30873249); 北京市自然科学基金(7122091); 中央民族大学自主科研项目(1112KYXJ09); 教育部"长江学者和创新团队发展计划"资助项目(IRT0871)
中文摘要:

目的 观察菩人丹(PuRenDan)对2型糖尿病胰腺微循环损伤大鼠胰腺组织中血管内皮生长因子(VEGF)及其受体(VEGFR2/p-VEGFR2)和血管生成抑制素(Angiostatin)、内皮细胞抑制素(Endostatin)的影响,探讨菩人丹修复胰腺微循环障碍的机制。方法 通过高脂饲料喂养(12周)与尾静脉快速注射小剂量链脲佐菌素(30mg/kg)的方法建立大鼠模型。在同批次正常大鼠中随机选15只为正常对照组,后将成模大鼠随机分为:模型组、菩人丹组(1.77g/kg)、降糖通脉片组(0.42g/kg)和二甲双胍组(0.14g/kg),每组15只。各组大鼠每天灌胃1次,正常对照组和模型组给予等剂量蒸馏水,连续给药4周后,提取各组大鼠胰腺组织总蛋白质,采用Westernblot法测定各组大鼠胰腺组织中VEGF及其受体VEGFR2的蛋白质表达和磷酸化水平,以及Angiostatin、Endostatin的蛋白质表达水平。结果 与正常对照组相比,模型组胰腺组织VEGF蛋白质表达水平和受体VEGFR2磷酸化水平明显降低(P〈0.01),而Angiostatin、Endostatin蛋白质表达水平显著增高(P〈0.01);菩人丹干预后,VEGF蛋白质表达水平和受体VEGFR2磷酸化水平均显著上调(P〈0.01),而Angiostatin、Endostatin蛋白质表达则被抑制(P〈0.01)。其与阳性对照药降糖通脉片和二甲双胍作用相当。结论 菩人丹通过上调血管生成促进因子VEGF蛋白质表达及其受体VEGFR2磷酸化,抑制血管生成抑制因子Angiostatin、Endostatin的蛋白质表达,促进糖尿病状态下胰腺组织微血管新生,进而改善胰腺微循环障碍,发挥其对胰岛β细胞的保护、修复作用。

英文摘要:

Objective To observe the impacts of puren pills on VEGF and its receptor(VEGFR2 / p- VEGFR2),Angiostatin and Endostatin in the rats of pancreas micro - circulatory damage of T2DM so as to explore the mechanism of puren pills for pancreas micro - circulatory disturbance. Methods The feeding with high fat diet(12 weeKs)and the rapid injection with streptozotocin of small dose(30 mg/ Kg)via the vein on the tail were used to establish rat model. Among the normal rats of same batch,15 rats were selected ran-domly to set up a normal control group. The modeled rats were randomized into a model group,a puren pills group(1. 77 g/ Kg),a jiangtang tongmai tablets group(0. 42 g/ Kg)and a metformin group(0. 14 g/ Kg),15 rats in each one. The gavage was given once every day in the rats of each group. The stilled water of same dose was used in the normal control group and the model group. The medication was given continuously for 4 weeKs. Af-terwards,the total protein was collected from pancreas tissue in the rats of each group. Western blot method was adopted to determine the protein expressions of VEGF and VEGFR2 and the level of phosphorylation,as well as the protein expressions of Angiostatin and Endostatin. Results Compared with the normal control group, the protein expression of VEGF in pancreas tissue and the phosphorylation level of VEGFR2 were reduced apparently(P ﹤ 0. 01),and the protein expressions of Angiostatin and Endostatin were increased significantly (P ﹤ 0. 01). After the intervention with puren pills,the protein expression of VEGF in pancreas tissue and the phosphorylation level of VEGFRs were up - regulated significantly(P ﹤ 0. 01)and the protein expressions of Angiostatin and Endostatin were inhibited(P ﹤ 0. 01). The effects were similar to those in the positive con-trol groups treated with jiangtang tongmai tablets and metformin. Conclusion Puren pills up - regulate the protein expression of VEGF in pancreas tissue and the phosphorylation level of

同期刊论文项目
同项目期刊论文
期刊信息
  • 《世界中西医结合杂志》
  • 中国科技核心期刊
  • 主管单位:中国科学技术协会
  • 主办单位:中华中医药学会
  • 主编:路志正
  • 地址:北京市朝阳区北土城西路11号北京城建开发大厦东座303室
  • 邮编:100101
  • 邮箱:sjzxyjh@126.com
  • 电话:010-82275991
  • 国际标准刊号:ISSN:1673-6613
  • 国内统一刊号:ISSN:11-5511/R
  • 邮发代号:80-538
  • 获奖情况:
  • 第四届全国中医药优秀期刊二等奖,中年中医药学会中医药标志性文化(徽标)一等奖,获中国简直协精品科技期刊工程项目赞助国外数...,美国<<乌利希期刊指南>>收录
  • 国内外数据库收录:
  • 英国农业与生物科学研究中心文摘,波兰哥白尼索引,美国剑桥科学文摘,中国中国科技核心期刊
  • 被引量:13993